Form 6-K
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of August, 2013

Commission File Number 1-10928

 

 

INTERTAPE POLYMER GROUP INC.

 

 

9999 Cavendish Blvd., Suite 200, Ville St. Laurent, Quebec, Canada, H4M 2X5

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F  x            Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    INTERTAPE POLYMER GROUP INC.
Date: August 14, 2013     By:  

/s/ Bernard J. Pitz

      Bernard J. Pitz, Chief Financial Officer


Table of Contents

Intertape Polymer Group Inc.

Interim Condensed Consolidated Financial Statements

June 30, 2013

 

Unaudited Interim Condensed Consolidated Financial Statements

  

Consolidated Earnings (Loss)

     2   

Consolidated Comprehensive Income (Loss)

     3   

Consolidated Changes in Shareholders’ Equity

     4 to 5   

Consolidated Cash Flows

     6   

Consolidated Balance Sheets

     7   

Notes to Interim Condensed Consolidated Financial Statements

     8 to 18   


Table of Contents

Intertape Polymer Group Inc.

Consolidated Earnings (Loss)

Periods ended June 30,

(In thousands of US dollars, except per share amounts)

(Unaudited)

 

 

 

     Three months ended
June 30,
    Six months ended
June 30,
 
     2013      2012     2013     2012  
     $      $     $     $  

Revenue

     193,462        197,751        390,157       396,663   

Cost of sales

     151,202        161,629        309,591       328,134   
  

 

 

    

 

 

   

 

 

   

 

 

 

Gross profit

     42,260        36,122        80,566       68,529   
  

 

 

    

 

 

   

 

 

   

 

 

 

Selling, general and administrative expenses

     20,208        20,653        43,167       39,026   

Research expenses

     1,589        1,650        3,191       3,169   
  

 

 

    

 

 

   

 

 

   

 

 

 
     21,797        22,303        46,358       42,195   
  

 

 

    

 

 

   

 

 

   

 

 

 

Operating profit before manufacturing facility closures, restructuring and other related charges

     20,463        13,819        34,208       26,334   

Manufacturing facility closures, restructuring and other related charges

     924        14,152        28,125       14,698   
  

 

 

    

 

 

   

 

 

   

 

 

 

Operating profit (loss)

     19,539        (333     6,083       11,636   

Finance costs

         

Interest

     1,846        3,384        3,599       6,739   

Other expense

     437        667        597       1,140   
  

 

 

    

 

 

   

 

 

   

 

 

 
     2,283        4,051        4,196       7,879   
        .       

Earnings (loss) before income tax expense (benefit)

     17,256        (4,384     1,887       3,757   

Income tax expense (benefit) (Note 8)

         

Current

     1,909        353        2,660       846   

Deferred

     226        (848     (86 )     (909
  

 

 

    

 

 

   

 

 

   

 

 

 
     2,135        (495     2,574       (63
  

 

 

    

 

 

   

 

 

   

 

 

 

Net earnings (loss)

     15,121        (3,889     (687 )     3,820   
  

 

 

    

 

 

   

 

 

   

 

 

 

Earnings (loss) per share

         

Basic

     0.25        (0.07     (0.01 )     0.06   

Diluted

     0.25        (0.07     (0.01 )     0.06   

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements. Note 4 presents additional information on consolidated earnings (loss).

 

2


Table of Contents

Intertape Polymer Group Inc.

Consolidated Comprehensive Income (Loss)

Periods ended June 30,

(In thousands of US dollars)

(Unaudited)

 

 

 

     Three months ended
June 30,
    Six months ended
June 30,
 
     2013     2012     2013     2012  
     $     $     $     $  

Net earnings (loss)

     15,121        (3,889 )     (687     3,820   
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss)

        

Changes in fair value of forward foreign exchange rate contracts, designated as cash flow hedges (net of deferred income tax expense, nil in 2012)

     —          (112 )     —          226   

Settlements of forward foreign exchange rate contracts, transferred to earnings (net of income tax expense, nil in 2012)

     —          (394 )     —          (195

Change in cumulative translation adjustments

     (2,272     (2,487 )     (4,266     (649
  

 

 

   

 

 

   

 

 

   

 

 

 

Items that will be reclassified subsequently to net earnings (loss)

     (2,272     (2,993 )     (4,266     (618
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive loss

     (2,272     (2,993 )     (4,266     (618
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income (loss) for the period

     12,849        (6,882 )     (4,953     3,202   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

3


Table of Contents

Intertape Polymer Group Inc.

Consolidated Changes in Shareholders’ Equity

Six months ended June 30, 2012

(In thousands of US dollars, except for number of common shares)

(Unaudited)

 

 

 

    Capital stock           Accumulated other comprehensive income              
    Number     Amount     Contributed
surplus
    Cumulative
translation
adjustment
account
    Reserve for
cash flow
hedges
    Total     Deficit     Total
shareholders’
equity
 
          $     $     $     $     $     $     $  

Balance as of December 31, 2011

    58,961,050       348,148        16,611       1,206        (13     1,193        (228,774 )     137,178   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Transactions with owners

               

Exercise of stock options

    50,000       123                  123   

Stock-based compensation expense

        284               284   
 

 

 

   

 

 

   

 

 

           

 

 

 
    50,000       123        284               407   
 

 

 

   

 

 

   

 

 

           

 

 

 

Net earnings

                3,820       3,820   

Other comprehensive income (loss)

               

Changes in fair value of forward foreign exchange rate contracts, designated as cash flow hedges (net of deferred income tax expense of nil)

            226        226          226   

Settlement of forward foreign exchange rate contracts, transferred to earnings (net of income tax expense of nil)

            (195     (195       (195

Changes to cumulative translation adjustments

          (649       (649       (649
       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income for the period

          (649     31        (618     3,820       3,202   
       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of June 30, 2012

    59,011,050       348,271        16,895       557        18        575        (224,954 )     140,787   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

4


Table of Contents

Intertape Polymer Group Inc.

Consolidated Changes in Shareholders’ Equity

Six months ended June 30, 2013

(In thousands of US dollars, except for number of common shares)

(Unaudited)

 

 

 

     Capital stock      Contributed
surplus
    Accumulated
other
comprehensive
loss
    Deficit     Total
shareholders’
equity
 
     Number      Amount        Cumulative
translation
adjustment
account
     
            $      $     $     $     $  

Balance as of December 31, 2012

     59,625,039        351,702         16,386       3,208        (217,462 )     153,834   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Transactions with owners

              

Exercise of stock options

     1,071,610        3,623               3,623   

Excess tax benefit on stock options

        1,983               1,983   

Stock-based compensation expense

           290           290   

Stock-based compensation expense credited to capital on options exercised

        1,451         (1,451 )         —     

Dividends on common stock

               (4,799 )     (4,799
  

 

 

    

 

 

    

 

 

     

 

 

   

 

 

 
     1,071,610        7,057         (1,161 )       (4,799 )     1,097   
  

 

 

    

 

 

    

 

 

     

 

 

   

 

 

 

Net loss

               (687 )     (687

Other comprehensive loss

              

Changes to cumulative translation adjustments

             (4,266       (4,266
          

 

 

   

 

 

   

 

 

 

Comprehensive loss for the period

             (4,266     (687 )     (4,953
          

 

 

   

 

 

   

 

 

 

Balance as of June 30, 2013

     60,696,649        358,759         15,225        (1,058     (222,948 )     149,978   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

5


Table of Contents

Intertape Polymer Group Inc.

Consolidated Cash Flows

Periods ended June 30,

(In thousands of US dollars)

(Unaudited)

 

 

 

     Three months ended
June 30,
    Six months ended
June 30,
 
     2013     2012     2013     2012  
     $     $     $     $  

OPERATING ACTIVITIES

        

Net earnings (loss)

     15,121        (3,889 )     (687     3,820   

Adjustments to net earnings (loss)

        

Depreciation and amortization

     6,816        7,637       13,909        15,225   

Income tax expense (benefit)

     2,135        (495 )     2,574        (63

Interest expense

     1,846        3,384       3,599        6,739   

Charges in connection with manufacturing facility closures, restructuring and other related charges

     24        13,042       23,319        13,428   

Reversal of write-down of inventories, net

     —          (57 )     —          (31

Stock-based compensation expense

     880        231       2,720        374   

Pension and other post-retirement benefits expense

     758        755       1,519        1,511   

(Gain) loss on foreign exchange

     120        (128 )     20        104   

Other adjustments for non-cash items

     53        159       (61     359   

Income taxes paid, net

     (544     (653 )     (70     (654

Contributions to defined benefit plans

     (1,459     (2,010 )     (2,033     (2,781
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from operating activities before changes in working capital items

     25,750        17,976       44,809        38,031   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes in working capital items

        

Trade receivables

     2,222        1,570       (9,764     (9,039

Inventories

     (6,711     (3,424 )     (9,414     (7,570

Parts and supplies

     (266     (310 )     (415     (615

Other current assets

     (2,790     (2,599 )     278        (136

Accounts payable and accrued liabilities

     1,957        2,560       (1,834     2,343   

Provisions

     (1,053     864       2,573        405   
  

 

 

   

 

 

   

 

 

   

 

 

 
     (6,641     (1,339 )     (18,576     (14,612
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from operating activities

     19,109        16,637       26,233        23,419   
  

 

 

   

 

 

   

 

 

   

 

 

 

INVESTING ACTIVITIES

        

Proceeds on the settlements of forward foreign exchange rate contracts

     —          300       —          100   

Purchase of property, plant and equipment

     (18,176     (3,777 )     (24,001     (8,509

Proceeds from disposals of property, plant and equipment and other assets

     —          —          1,645        20   

Restricted cash and other assets

     363        311       427        283   

Purchase of intangible assets

     (71     (20 )     (71     (27
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities

     (17,884     (3,186 )     (22,000     (8,133
  

 

 

   

 

 

   

 

 

   

 

 

 

FINANCING ACTIVITIES

        

Proceeds from long-term debt

     40,233        5,720       51,320        26,346   

Repayment of long-term debt

     (33,338     (16,623 )     (46,169     (31,228

Payments of debt issue costs

     (88     (12 )     (102     (1,459

Interest paid

     (1,475     (654 )     (4,008     (6,331

Dividends paid

     (4,799     —          (4,799     —     

Proceeds from exercise of stock options

     2,377        123       3,662        123   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities

     2,910        (11,446 )     (96     (12,549
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in cash

     4,135        2,005       4,137        2,737   

Effect of foreign exchange differences on cash

     (112     (294 )     (209     (183

Cash, beginning of period

     5,796        5,188       5,891        4,345   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash, end of period

     9,819        6,899       9,819        6,899   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

6


Table of Contents

Intertape Polymer Group Inc.

Consolidated Balance Sheets

As of

(In thousands of US dollars)

 

 

 

     June  30,
2013

(Unaudited)
    December 31,
2012
(Audited)
 
     $     $  

ASSETS

    

Current assets

    

Cash

     9,819       5,891   

Trade receivables

     85,150       75,860   

Other receivables

     4,502       5,163   

Inventories (Note 6)

     100,075       91,910   

Parts and supplies

     13,469       14,442   

Prepaid expenses

     5,934       5,701   
  

 

 

   

 

 

 
     218,949       198,967   

Property, plant and equipment (Note 7)

     169,835       185,592   

Other assets

     3,414       3,597   

Intangible assets

     1,670       1,980   

Deferred tax assets

     34,181       36,016   
  

 

 

   

 

 

 

Total assets

     428,049       426,152   
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Accounts payable and accrued liabilities

     74,752       76,005   

Provisions (Note 10)

     2,709       1,526   

Installments on long-term debt (Note 9)

     11,506       9,688   
  

 

 

   

 

 

 
     88,967       87,219   

Long-term debt (Note 9)

     145,814       141,611   

Pension and other post-retirement benefits

     39,919       40,972   

Provisions (Note 10)

     3,166       1,891   

Other liabilities

     205       625   
  

 

 

   

 

 

 
     278,071       272,318   
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Capital stock (Note 11)

     358,759       351,702   

Contributed surplus

     15,225       16,386   

Deficit

     (222,948 )     (217,462

Accumulated other comprehensive income (loss)

     (1,058 )     3,208   
  

 

 

   

 

 

 
     149,978       153,834   
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

     428,049       426,152   
  

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

7


Table of Contents

Intertape Polymer Group Inc.

Notes to Interim Condensed Consolidated Financial Statements

June 30, 2013

(In US dollars, tabular amounts in thousands, except as otherwise noted)

(Unaudited)

 

 

 

1 - GENERAL BUSINESS DESCRIPTION

Intertape Polymer Group Inc. (the “Parent Company”), incorporated under the Canada Business Corporations Act, has its principal administrative offices in Montreal, Quebec, Canada and in Sarasota-Bradenton, Florida, U.S.A. The address of the Parent Company’s registered office is 1250 René-Lévesque Blvd. West, Suite 2500, Montreal, Quebec, Canada H3B 4Y1, c/o Heenan Blaikie LLP. The Parent Company’s common shares are listed on the Toronto Stock Exchange (“TSX”) in Canada.

The Parent Company and its subsidiaries (together referred to as the “Company”), develop, manufacture and sell a variety of paper and film based pressure sensitive and water activated tapes, specialized polyolefin films, woven fabrics and complementary packaging systems for industrial and retail use.

Intertape Polymer Group Inc. is the group’s ultimate parent.

 

2 - ACCOUNTING POLICIES

Basis of Presentation and Statement of Compliance

The unaudited interim condensed consolidated financial statements (“financial statements”) present the Company’s consolidated balance sheets as of June 30, 2013 and December 31, 2012, as well as its interim consolidated earnings (loss), comprehensive income (loss) and cash flows for the three and six months ended June 30, 2013 and 2012, and the changes in shareholders’ equity for the six months ended June 30, 2013 and 2012. These financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34 – Interim Financial Reporting and are expressed in US dollars. Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with International Financial Reporting Standards (“IFRS”), as issued by the International Accounting Standards Board (“IASB”), have been omitted or condensed.

Estimates

When preparing the financial statements, management undertakes a number of judgments, estimates and assumptions about recognition and measurement of assets, liabilities, income and expenses. The actual results may differ from the judgments, estimates and assumptions made by management, and will seldom equal the estimated results. The judgments, estimates and assumptions applied in the financial statements, including the key sources of estimation uncertainty, were the same as those applied in the Company’s most recent annual audited consolidated financial statements. The only exceptions are the estimate of the provision for income taxes which is determined in the financial statements using the estimated weighted average annual effective income tax rate applied to the pre-tax income of the interim period and the item discussed in Note 3. These financial statements and notes should be read in conjunction with the Company’s most recent annual audited consolidated financial statements.

Presentation of items of other comprehensive income (loss)

Amended IAS 1 – Presentation of Financial Statements: requires entities to group items presented in other comprehensive income (loss) (“OCI”) into those that, in accordance with other IFRS, will be reclassified subsequently to earnings or loss and those that will not be reclassified subsequently to earnings or loss when specific conditions are met. The existing option to present items of OCI either before tax or net of tax remains unchanged: however, if the items are presented before tax then amended IAS 1 requires the tax related to each of the two groups of OCI to be shown separately.

 

8


Table of Contents

These financial statements reflect all adjustments which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. These adjustments are of a normal recurring nature.

These financial statements were authorized for issuance by the Company’s Board of Directors on August 14, 2013.

New Standards and Interpretations Issued But Not Yet Effective

Certain new standards, amendments and interpretations, and improvements to existing standards have been issued by the IASB but are not yet effective, and have not been adopted by the Company. Management anticipates that all of the relevant pronouncements will be adopted by the first period beginning the date of the pronouncement. Information on new standards, amendments and interpretations, and improvements to existing standards, which could potentially impact the Company’s financial statements are detailed as follows:

IFRS 9 – Financial Instruments and IFRS 7 – Financial Instruments: Disclosures: The IASB intends to replace IAS 39 Financial Instruments: Recognition and Measurement in its entirety. The replacement standard (IFRS 9) is being issued in phases. To date, the chapters dealing with recognition, classification, measurement and derecognition of financial assets and liabilities have been issued. These chapters are effective for annual periods beginning on or after January 1, 2015. Further chapters dealing with impairment methodology and hedge accounting are still being developed. IFRS 7 has been amended to require disclosures that are either permitted or required on the basis of the entity’s date of adoption of IFRS 9 and whether the entity elects to restate prior periods under IFRS 9 and is effective for annual periods beginning on or after January 1, 2015. Management has yet to assess the impact that these amendments are likely to have on the financial statements of the Company.

Certain other new standards and interpretations have been issued but are not expected to have a material impact on the Company’s financial statements.

 

3 - PENSION AND OTHER POST-RETIREMENT BENEFIT PLANS

As noted in the March 31, 2013 Interim Condensed Consolidated Financial Statements, the Company adopted Amended IAS 19 – Employee Benefits on January 1, 2013.

Amended IAS 19 – Employee Benefits: Amended for annual periods beginning on or after January 1, 2013 with retrospective application, introduced a measure of net interest income (expense) computed on the net pension asset (obligation) that replaced separate measurement of the expected return on plan assets and interest expense on the benefit obligation. The amended standard also required immediate recognition of past service costs associated with benefit plan changes; eliminating the requirement to recognize over the vesting period.

Upon retrospective application of the amended standard, the Company’s net earnings for 2012 were lower than originally reported. The decrease arose primarily because net interest income (expense) was calculated using the discount rate used to value the benefit obligation, which is lower than the expected rate of return on assets previously used to measure interest attributable to plan assets. On a quarterly basis, this also resulted in an income tax benefit and an increase to the net pension liability.

 

9


Table of Contents

The impact of these changes for the three and six month periods ended June 30, 2012 is summarized as follows:

 

     Three months ended
June 30, 2012
    Six months ended
June 30, 2012
 
     As
Reported
    IAS 19
Adjustment
    Adjusted     As
Reported
    IAS 19
Adjustment
    Adjusted  
     $     $     $     $     $     $  

Revenue

     197,751        —          197,751        396,663         396,663   

Cost of sales

     161,124        505       161,629        327,124       1,010        328,134   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     36,627        (505 )     36,122        69,539       (1,010     68,529   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Selling, general and administrative expenses

     20,653        —          20,653        39,026       —          39,026   

Research expenses

     1,650        —          1,650        3,169       —          3,169   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     22,303        —          22,303        42,195       —          42,195   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating profit before manufacturing facility closures, restructuring and other related charges

     14,324        (505 )     13,819        27,344       (1,010     26,334   

Manufacturing facility closures restructuring and other related charges

     14,152        —          14,152        14,698       —          14,698   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating profit (loss)

     172        (505 )     (333     12,646       (1,010     11,636   

Finance costs

            

Interest

     3,384        —          3,384        6,739       —          6,739   

Other expense

     667        —          667        1,140       —          1,140   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     4,051        —          4,051        7,879       —          7,879   
     .          .        .          .   

Earnings (loss) before income tax expense (benefit)

     (3,879     (505 )     (4,384     4,767       (1,010     3,757   

Income tax expense (benefit)

            

Current

     353        —          353        846       —          846   

Deferred

     (807     (41 )     (848     (827 )     (82     (909
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     (454     (41 )     (495     19       (82     (63
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net earnings (loss)

     (3,425     (464 )     (3,889     4,748       (928     3,820   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) per share

            

Basic

     (0.06     (0.01 )     (0.07     0.08       (0.02     0.06   

Diluted

     (0.06     (0.01 )     (0.07     0.08       (0.02     0.06   

For the years ended December 31, 2012 and 2011, the impact of adoption is a decrease to earnings before income tax benefit of $2.3 million and $1.7 million, respectively and an income tax benefit of $0.2 million for each of these years. This impact also results in an equivalent net increase to other comprehensive income and deficit. As such, the retrospective application did not result in an impact to the Company’s balance sheets as of January 1, 2012 and December 31, 2012.

The Company’s interim consolidated cash flows were not significantly impacted.

 

10


Table of Contents
4 - INFORMATION INCLUDED IN CONSOLIDATED EARNINGS (LOSS)

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2013      2012      2013      2012  
     $      $      $      $  

Employee benefit expense

           

Wages, salaries and other short-term benefits

     33,801        32,227         69,372        65,985   

Stock-based compensation expense

     880        231         2,720        374   

Pensions – defined benefit plans

     786        784         1,575        1,559   

Pensions – defined contribution plans

     934        1,089         1,861        1,946   
  

 

 

    

 

 

    

 

 

    

 

 

 
     36,401        34,331         75,528        69,864   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three months ended
June 30,
    Six months ended
June 30,
 
     2013     2012     2013     2012  
     $     $     $     $  

Finance costs – Interest

        

Interest on long-term debt

     1,590       3,170        3,212       6,317   

Amortization of debt issue costs on long-term debt and asset-based loan

     354       277        591       560   

Interest capitalized to property, plant and equipment

     (98 )     (63     (204 )     (138
  

 

 

   

 

 

   

 

 

   

 

 

 
     1,846       3,384        3,599       6,739   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2013      2012      2013      2012  
     $      $      $      $  

Finance costs – Other (income) expense

           

Foreign exchange loss

     120         333        21         295   

Other (income) expense and other finance costs, net

     317         334        576         845   
  

 

 

    

 

 

    

 

 

    

 

 

 
     437         667        597         1,140   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2013      2012      2013      2012  
     $      $      $      $  

Additional information

           

Depreciation of property, plant and equipment

     6,645        7,424         13,563        14,797   

Amortization of intangible assets

     171        213         346        428   

Amortization of other charges

     5        24         10        45   

Impairment of long-term assets

     168        11,130         22,092        11,130   

Loss on disposal of property, plant and equipment

     28        75         58        315   

Write-down of inventories to net realizable value

     —           —           —           57   

Reversal of write-down of inventories to net realizable value, recognized as a reduction of cost of sales

     —           —           —           (88

 

11


Table of Contents
5 - MANUFACTURING FACILITY CLOSURES, RESTRUCTURING, AND OTHER RELATED CHARGES

The following table describes the charges incurred by the Company in connection with its restructuring efforts, which are included in the Company’s consolidated earnings (loss) for the three and six months ended June 30, 2013 and 2012 under the caption manufacturing facility closures, restructuring and other related charges:

 

     Three months ended
June 30, 2013
    Six months ended
June 30, 2013
 
     South
Carolina
project
     Other
projects
    Total     South
Carolina
project
     Other
projects
    Total  
     $      $     $     $      $     $  

Impairment (reversal) of property, plant and equipment

     24         (11     13       22,213         (276 )     21,937   

Impairment (reversal) of parts and supplies

     —           (31     (31 )     1,312         (31 )     1,281   

Equipment relocation

     —           498        498       —           1,572       1,572   

Reversal of write-down of inventories to net realizable value

     —           (48     (48 )     —           (78 )     (78

Severance and other labor related costs

     203         21        224       203         62       265   

Environmental costs

     —           —          —          2,522         —          2,522   

Idle facility costs

     —           200        200       —           533       533   

Other costs

     54         14        68       58         35       93   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 
     281         643        924       26,308         1,817       28,125   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 
     Three months ended
June 30, 2012
    Six months ended
June 30, 2012
 
     South
Carolina
project
     Other
projects
    Total     South
Carolina
project
     Other
projects
    Total  
     $      $     $     $      $     $  

Impairment of property, plant and equipment

     —           10,627        10,627       —           10,627       10,627   

Impairment of parts and supplies

     —           1,167        1,167       —           1,167       1,167   

Impairment of intangible assets

     —           503        503       —           503       503   

Write-down of inventories to net realizable value

     —           488        488       —           488       488   

Severance and other labor related costs

     —           1,195        1,195       —           1,195       1,195   

Idle facility costs

     —           172        172       —           718       718   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 
     —           14,152        14,152       —           14,698       14,698   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

On February 26, 2013, the Company announced its intention to relocate its Columbia, South Carolina manufacturing facility within the region in order to modernize facility operations and acquire state-of-the-art manufacturing equipment. The charges incurred are included in the table above under South Carolina project.

In 2013, the other charges incurred are the incremental costs of the ongoing Richmond, Kentucky manufacturing facility closure, consolidation of the shrink film production from Truro, Nova Scotia to Tremonton, Utah, other small restructuring initiatives and the Brantford, Ontario facility closure and are included in the table above under Other projects.

 

12


Table of Contents

In 2012, the charges incurred are primarily the costs of the Richmond, Kentucky manufacturing facility closure, consolidation of the shrink film production from Truro, Nova Scotia to Tremonton, Utah and other small restructuring initiatives and are included in the table above under Other projects. The Idle facility charges under Other projects are primarily related to the revaluation of certain Brantford, Ontario facility assets in connection with the Brantford, Ontario facility closure.

 

6 - INVENTORIES

 

     June 30,
2013
     December 31,
2012
 
     $      $  

Raw materials

     26,085          27,856   

Work in process

     19,485          19,904   

Finished goods

     54,505        44,150   
  

 

 

    

 

 

 
     100,075        91,910   
  

 

 

    

 

 

 

The amount of inventories recognized as an expense during the period corresponds to cost of sales.

 

7 - PROPERTY, PLANT AND EQUIPMENT

During the three and six months ended June 30, 2013, acquisitions of property, plant and equipment amounted to approximately $18.2 million and $24.0 million, respectively ($3.8 million and $8.5 million for the three and six months ended June 30, 2012, respectively). During the three and six months ended June 30, 2013, the net book value of property, plant and equipment disposals amounted to less than $0.1 million and $1.5 million, respectively ($0.1 million and $0.3 million for the three and six months ended June 30, 2012, respectively) and the loss on those disposals amounted to less than $0.1 million ($0.1 million and $0.3 million loss for the three and six months ended June 30, 2012, respectively).

On June 28, 2013, in connection with the relocation of the Columbia, South Carolina manufacturing facility, the Company purchased real estate including land and building of $11.3 million in Blythewood, South Carolina. The purchase is included under the caption property, plant and equipment in construction in progress as the real estate is being prepared for its intended use and is expected to be placed into service in a future period.

As of June 30, 2013 and December 31, 2012, the Company had commitments to purchase machines and equipment totaling approximately $5.7 million and $5.5 million, respectively.

During the three and six months ended June 30, 2013, the Company recorded impairment losses on idle assets of $0.2 million (nil for the three and six months ended June 30, 2012) and were included in the statement of consolidated earnings (loss) under the caption cost of sales and the statement of consolidated cash flows under the caption other adjustments for non-cash items. There were no reversals of impairment losses during the current and comparative reporting periods, other than those discussed in Note 5 and included in the statement of consolidated earnings (loss) under the caption manufacturing facility closures, restructuring and other related charges.

 

8 - INCOME TAXES

Income tax expense (benefit) is recognized in each interim period based on the best estimate of the weighted average annual income tax rate expected for the full financial year. Amounts accrued for income tax expense (benefit) in one interim period may have to be adjusted in a subsequent interim period of the financial year if the estimate of the annual income tax rate changes. The effective tax rate for the three and six months ended June 30, 2013 was approximately 12.4% and 136.4%, respectively (11.3% and negative 1.7% for the three and six months ended June 30, 2012, respectively). The increase in effective tax rate between the three months ended June 30, 2013 and the three months ended June 30, 2012 is primarily due to income tax expense recorded for stock options exercised, the impact of the nonrecurrence of US alternative minimum tax recorded on losses before income tax expense due to the

 

13


Table of Contents

ability in the second quarter of 2013 to utilize certain US alternative minimum tax net operating losses without limitation, an increase in the state effective tax rate due to the combination of higher earnings before income tax expense in the second quarter of 2013 resulting from lower manufacturing rationalization charges and an increase in state income taxes due to a decrease in the amount of state net operating loss carryforwards available in certain states; and the expected change in the apportionment of taxable income by province in Canada. These increases to the effective tax rate were offset by a significant change in earnings before income tax expense in a jurisdiction for which the Company does not record deferred tax assets. The increase in effective tax rate between the six months ended June 30, 2013 and the six months ended June 30, 2012 is primarily due to income tax expense recorded for stock options exercised, an increase in state income taxes resulting from a decrease in the amount of state net operating loss carryforwards available in certain states and the combination of an increase in state taxable income with a reduction in earnings before income tax expense due to higher manufacturing rationalization charges; and the expected change in the apportionment of taxable income by province in Canada. These increases were offset by the benefit received from the ability in the first six months of 2013 to utilize certain US alternative minimum tax net operating losses without limitation.

 

9 - LONG-TERM DEBT

 

     June 30,
2013
     December 31,
2012
 
     $      $  

Senior Subordinated Notes (“Notes”) (1)

     18,564        38,282   

Asset-Based Loan (“ABL”) (1)

     94,033        77,709   

Real estate secured term loan (“Real Estate Loan”) (1)

     15,026        15,632   

Finance lease liabilities

     12,694        10,979   

Term debt

     1,081        2,576   

Mortgage loans (1)

     9,919        1,504   

Equipment finance agreement advance fundings

     6,003        4,617   
  

 

 

    

 

 

 
     157,320        151,299   

Less: Installments on long-term debt

     11,506        9,688   
  

 

 

    

 

 

 
     145,814        141,611   
  

 

 

    

 

 

 

 

(1) 

The Notes, ABL, Real Estate Loan and mortgage loans are presented net of unamortized related debt issue costs, amounting to $2.4 million ($3.0 million as of December 31, 2012).

As of June 30, 2013 and December 31, 2012, the effective interest rate on borrowings under the ABL was 2.37% and 2.36%, respectively.

The Company’s unused availability under the ABL as of June 30, 2013 and December 31, 2012 was $41.8 million and $48.8, respectively.

The ABL has one financial covenant, a fixed charge ratio of greater than or equal to 1.0 to 1.0. The financial covenant becomes effective only when unused availability drops below $25.0 million. Although not in effect, the Company was in compliance with this fixed charge ratio covenant as of June 30, 2013.

Equipment finance agreement advance fundings, which are amounts funded and borrowed but not yet scheduled, were $6.0 million as of June 30, 2013. Advance fundings accrue interest at the 30-day LIBOR rate plus 200 basis points resulting in an interest rate of 2.19% as of June 30, 2013. The Company entered into the third schedule on June 28, 2013 for $2.2 million at an interest rate of 2.9% with 60 monthly payments of $39,329 and the last payment due on June 27, 2018.

The Real Estate Loan contains two financial covenants, both of which are determined at the end of each fiscal month. The Company has been in compliance with these covenants since entering into the Real Estate Loan.

 

14


Table of Contents

On May 14, 2013, the Company announced a notice of redemption to redeem the aggregate principal amount of $20.0 million of its outstanding 8.5% Notes due August 2014. The redemption of $20.0 million of the Notes occurred on June 27, 2013. The Company financed the redemption with funds available under the ABL combined with its cash flows from operations. The corresponding expense write-off of debt issue costs of $0.2 million was recorded in interest under the caption finance costs in the statement of consolidated earnings (loss).

On June 28, 2013, the Company purchased real estate in Blythewood, South Carolina for $11.3 million and entered into a mortgage (“South Carolina Mortgage”) on the real estate for up to $10.7 million, $8.5 million of which was advanced upon closing of the purchase of the property. Interest will be payable monthly and principal will be amortized on a straight-line basis over ten years. The loan provides for an additional advance of $2.1 million upon completion of building improvements, subject to an appraisal. The loan had a net book value of $8.5 million as of June 30, 2013. The maturity of the loan may be accelerated if the ABL facility is not extended, refinanced with a credit facility acceptable to Wells Fargo Bank, National Association (“Wells Fargo”), or if Wells Fargo ceases to be an ABL lender by reason of the action of the Company. The loan bears interest at a rate of 30-day LIBOR plus 215 basis points. The mortgage loan initially requires monthly payments of principal of $70,937.50 (subject to adjustment if the additional advance is made) plus accrued interest, with the first payment paid on July 15, 2013. In the event the additional $2.1 million is not advanced, a final payment of up to $7.2 million will be due on February 1, 2017 if the ABL facility is not extended or refinanced with a credit facility acceptable to Wells Fargo. The mortgage loan contains two financial covenants, a fixed charge coverage ratio of at least 1.1 to 1.0 and a cash flow leverage ratio of not greater than 3.5 to 1.0, both of which are measured monthly on a trailing 12-month basis. The Company has been in compliance with these covenants since entering into the mortgage loan. The loan is secured by the Company’s Blythewood, South Carolina real property and the building improvements thereon with a net book value of $11.3 million as of June 30, 2013.

A default under the Company’s ABL will be deemed a default under the Company’s South Carolina Mortgage, Real Estate Loan and Equipment Financing Agreement.

 

10 - PROVISIONS AND CONTINGENT LIABILITIES

The rollforward of the Company’s provisions is as follows as of June 30, 2013:

 

     Environmental      Restoration     Resolution of
a contingent
liability
    Severance
and other
    Total  
     $      $     $     $     $  

Balance, December 31, 2012

     —           1,891        —          1,526        3,417   

Additional provisions

     2,518        —          1,300       661        4,479   

Amounts paid

     —           (19     (1,000 )     (887     (1,906

Foreign exchange

     —           (74     —          (41     (115
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance, June 30, 2013

     2,518        1,798        300       1,259        5,875   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Amount presented as current

     —           1,313        300       1,096        2,709   

Amount presented as non-current

     2,518        485        —          163        3,166   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance, June 30, 2013

     2,518        1,798        300       1,259        5,875   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

The environmental provision pertains to the Columbia, South Carolina manufacturing facility. Refer to Note 5 for more information regarding the relocation of the Columbia, South Carolina manufacturing facility.

In February 2012, Multilayer Stretch Cling Film Holdings, Inc. (“Multilayer”) filed a complaint against the Company in the U.S. District Court for Western Tennessee, alleging that the Company had infringed a patent issued to Multilayer that covers certain aspects of the manufacture of stretch film. In May 2013, the Company agreed to a settlement of the outstanding litigation. Under the confidential settlement

 

15


Table of Contents

agreement, the Company will pay Multilayer an undisclosed amount in full settlement of all outstanding issues. The terms of the agreement do not restrict the sale of any of the Company’s products, as the Company’s current products do not utilize Multilayer’s patented invention. The Company does not expect that the settlement will have any material effect on the Company’s continuing operations. The Company established a provision with respect to this matter as of and for the three months ended March 31, 2013. The amount is included in the statement of consolidated earnings (loss) under the caption selling, general and administrative expenses and the consolidated balance sheet under the caption provisions within current liabilities.

In addition to the matter described above, the Company is engaged in various legal proceedings and claims that have arisen in the ordinary course of business. The outcome of all of the proceedings and claims against the Company is subject to future resolution, including the uncertainties of litigation. Based on information currently known to the Company and after consultation with outside legal counsel, management believes that the probable ultimate resolution of any such proceedings and claims, individually or in the aggregate, will not have a material adverse effect on the financial condition of the Company, taken as a whole, and accordingly, no additional amounts have been recorded as of June 30, 2013.

During the reporting period, there were no reversals of provisions.

 

11 - CAPITAL STOCK AND EARNINGS PER SHARE

Common Shares

The Company’s common shares outstanding as of June 30, 2013 and December 31, 2012 were 60,696,649 and 59,625,039, respectively.

The weighted average number of common shares outstanding for the periods ended June 30, are as follows:

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2013      2012      2013      2012  

Basic

     60,288,991         58,981,435        60,005,104         58,971,242   

Effect of stock options

     1,295,741         —           —           1,621,668   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted

     61,584,732         58,981,435        60,005,104         60,592,910   
  

 

 

    

 

 

    

 

 

    

 

 

 

For the three and six months ended June 30, 2013, the number of options that were anti-dilutive and not included in diluted earnings per share calculations were 747,500 and 2,311,677, respectively (3,283,526 and nil for the three and six months ended June 30, 2012, respectively).

The Company declared a cash dividend of $0.08 per common share paid on April 10, 2013 to shareholders of record at the close of business on March 25, 2013. The aggregate amount of this dividend payment was $4.8 million based on 59,983,184 shares of the Company’s common shares issued and outstanding as of March 25, 2013.

Stock Appreciation Rights

On June 28, 2012, 1,240,905 SARs were granted at an exercise price of CDN$7.56.

 

16


Table of Contents

As of June 30, 2013, the fair value per SAR outstanding was estimated as $5.73 using the Black-Scholes option pricing model, taking into account the following weighted average assumptions:

 

Expected life

     4.8 years   

Expected volatility

     43

Risk-free interest rate

     1.92

Expected dividends

     2.59

Stock price at grant date

   CDN$ 7.56   

Exercise price of awards

   CDN$ 7.56   

Expected volatility was calculated by applying a weighted average of the daily closing price change on the TSX for four years prior to the period end date for awards with a six year life, and six years for awards with a ten year life, with more weight placed on the more recent time periods.

During the three and six months ended June 30, 2013, $0.7 million and $2.4 million of expense is included under the caption selling, general and administrative expenses, respectively ($0.1 million for the three and six months ended June 30, 2012). The corresponding liability is recorded on the Company’s consolidated balance sheet respectively under the caption accounts payable and accrued liabilities for amounts vested and expected to vest in the next 12 months, and other liabilities for amounts expected to vest greater than 12 months.

During the three and six months ended June 30, 2013, 12,500 SARs were exercised at a weighted average exercise price of CDN$7.56 (nil for both the three and six months ended June 30, 2012), resulting in cash payments of approximately $40,000, subsequently paid in July (nil for the three and six months ended June 30, 2012).

During the three and six months ended June 30, 2013, 30,000 SARs were forfeited (nil options expired or were forfeited for the three and six months ended June 30, 2012).

Stock Options

During the three and six months ended June 30, 2013, 747,500 stock options were granted at a weighted average exercise price of CDN$12.04 and a fair value of $3.66.

The fair value of options granted was estimated using the Black-Scholes option pricing model, taking into account the following weighted average assumptions:

 

Expected life

     5.7 years   

Expected volatility

     43

Risk-free interest rate

     1.56

Expected dividends

     2.75

Share price

   CDN$ 12.04   

Exercise price

   CDN$ 12.04   

Expected volatility was calculated by applying a weighted average of the daily closing price change on the TSX for a term commensurate with the expected life of each grant, with more weight placed on the more recent time periods.

During the three and six months ended June 30, 2012 no options were granted.

During the three and six months ended June 30, 2013, 713,465 and 1,071,610 stock options were exercised at a weighted average exercise price of CDN$3.39 and CDN$3.47, respectively (50,000 for both the three and six months ended June 30, 2012 at a weighted average exercise price of CDN$2.49), resulting in cash proceeds to the Company of $2.4 million and $3.6 million, respectively ($0.1 million for the three and six months ended June 30, 2012).

 

17


Table of Contents

During the three and six months ended June 30, 2013, 21,250 options were forfeited (165,000 and 440,500 options expired or were forfeited for the three and six months ended June 30, 2012, respectively).

The weighted average exercise price and fair value per option outstanding as of June 30, 2013 was:

 

Exercise price

   CDN$ 5.26   

Fair value

   $ 1.92   

Contributed Surplus

During the three and six months ended June 30, 2013, the contributed surplus account increased approximately $0.2 million and $0.3 million, respectively ($0.1 million and $0.3 million for the three and six months ended June 30, 2012, respectively), representing the stock-based compensation expense recorded for the period associated with stock options. During the three and six months ended June 30, 2013, the contributed surplus account decreased approximately $0.7 million and $1.5 million, respectively (nil for the three and six months ended June 30, 2012), representing the stock-based compensation expense credited to capital stock on options exercised.

 

12 - FINANCIAL INSTRUMENTS

Fair value and classification of financial instruments

The fair value of the Company’s Notes as of June 30, 2013 and December 31, 2012, was $18.7 million and $38.7 million, respectively.

 

13 - POST REPORTING EVENTS

Adjusting Events

No adjusting events have occurred between the reporting date of these financial statements and the date of authorization.

Non-Adjusting Events

On August 14, 2013, the Company’s Board of Directors approved a change in the semi-annual dividend policy to a quarterly dividend policy. Under this quarterly dividend policy the Company declared a cash dividend of $0.08 per common share payable September 30, 2013 to shareholders of record at the close of business on September 16, 2013. The estimated amount of this dividend payment is $4.9 million based on 60,719,149 shares of the Company’s common shares issued and outstanding as of August 14, 2013.

On July 12, 2013, the Company’s Board of Directors approved the redemption, at par value, of the remaining $18.7 million aggregate principal amount of its outstanding 8.5% Notes due August 2014. The redemption of $18.7 million of the Notes will occur on August 30, 2013, at which time the Indenture will be discharged and all Notes satisfied. The Company will finance the redemption with funds available under the ABL combined with its cash flows from operations.

No other significant non-adjusting events have occurred between the reporting date of these financial statements and the date of authorization.

 

18